mecamylamine has been researched along with Arteriosclerosis in 1 studies
Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.
Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| SMITH, TH | 1 |
| ROSSI, GV | 1 |
1 other study available for mecamylamine and Arteriosclerosis
| Article | Year |
|---|---|
The effect of reserpine and mecamylamine on experimental atheromatosis in the normotensive and hypertensive rat.
Topics: Animals; Arteriosclerosis; Autonomic Agents; Blood Pressure; Cholesterol; Hypertension; Mecamylamine | 1962 |